Improved Management of Patients With Recent-Onset Stable Chest Pain
ConditionCoronary Artery Disease (CAD)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30+
SponsorPhilipps University Marburg
About this trial
In Germany, coronary CT offers an accurate and less burdensome alternative to cardiac catheterisation for evaluating suspected coronary artery disease, but it is still underused. The IMPRO stepped-wedge trial tests a new, nationwide care model (NVF) in 16 regions to improve guideline-based intersectoral implementation of coronary CT and assess its impact on cardiovascular outcomes and healthcare costs. If effective, the model of care (NVF) could be adopted across Germany to enhance care quality while reducing unnecessary procedures and expenses.
Eligibility criteria
Qualifiers
Age ≥30 years
Suspected CAD with stable chest pain
Ability to give informed consent
Disqualifiers
Known or previously treated (with PCI or CABG) obstructive CAD (defined as at least one coronary diameter stenosis ≥50%)
Acute coronary syndrome
Negative invasive coronary angiography or coronary CT within the last 5 years
Already enrolled in the study
Trial design
Treatments tested in this trial
- IMPRO - Cross-Sectoral Care Model for Coronary Diagnostics
Treatment groups
3,369 Participants
are divided into 2 treatment groupsSponsors and collaborators
Philipps University Marburg
Lead sponsor
Gemeinsamer Bundesaussschuss
Collaborator
Source ClinicalTrials.gov